Iranian Heart Journal

Iranian Heart Journal

Assessment of the Incidence of In-Stent Restenosis and Its Associated Risk Factors Following Percutaneous Coronary Angioplasty: A Cross-Sectional Study

Document Type : Original Article

Authors
Pegah Asadi 1
Farzad Shahsanaei 1
Shahin Abbaszadeh 1
Soudabeh Behrooj 1
Amir Hasan Asadi 2
1 Cardiovascular Research Center, Hormozgan University of Medical Sciences, Bandar Abbas, IR Iran.
2 Department of Emergency Medicine, Hormozgan University of Medical Sciences, Bandar Abbas, IR Iran.
Abstract
Background: In-stent restenosis remains a significant concern for cardiologists, as it can lead to recurrent angioplasty, coronary artery bypass surgery, myocardial infarction, or death. This study aimed to evaluate the incidence of in-stent restenosis and associated risk factors following percutaneous coronary angioplasty with drug-eluting stents in patients referred to Shahid Mohammadi Hospital between 2020 and 2022.
 
Methods: This cross-sectional study examined 586 patients with coronary syndrome who underwent coronary angioplasty with stent implantation at Shahid Mohammadi Hospital, Bandar Abbas, Iran, between 2020 and 2022. A researcher-developed checklist was used to collect data on demographic characteristics, clinical findings, and stent-related information from clinical records. Additional data was obtained through telephone interviews with patients as needed. IBM SPSS Statistics software (Version 26) was employed for data analysis, with a significance level below 0.05. The association between coronary restenosis incidence and related factors was evaluated using multivariate logistic regression analysis.
 
Results: Of the 586 patients included in this study, 335 (57.2%) were male, with a mean age of 56.86 ± 14.61 years. The incidence of in-stent restenosis was 20.8%. Multivariate logistic regression analysis identified several independent risk factors associated with coronary artery restenosis, including hyperlipidemia, diabetes, opium use, a higher number of stents implanted, smaller stent diameter, and increased stent length of intracoronary stents.
 
Conclusions: Recognizing the risk factors for in-stent restenosis can substantially aid healthcare providers in making informed decisions, ultimately leading to improved prevention strategies and overall management for patients with coronary artery disease. A multidisciplinary approach, including addressing modifiable risk factors such as hyperlipidemia, diabetes, and opium use, as well as optimizing stent selection and placement techniques, may contribute to better long-term outcomes for these patients. (Iranian Heart Journal 2024; 25(4): 31-42)
Keywords
Acute coronary syndrome
Angioplasty
Stent placement
In-stent restenosis
medical stenosis
  1. Tahmasebi, H., et al., The Impact of Aromatherapy on the Anxiety of Patients Experiencing Coronary Angiography. Zahedan J Res Med Sci, 2012. 14(3): p. e93565.
  2. Ripley, D.P., et al., Established and emerging cardiovascular magnetic resonance techniques for the assessment of stable coronary heart disease and acute coronary syndromes. Quant Imaging Med Surg, 2014. 4(5): p. 330-44.
  3. Yadav, A., et al., Effect of yoga regimen on lung functions including diffusion capacity in coronary artery disease patients: A randomized controlled study. International Journal of Yoga, 2015. 8(1): p. 62.
  4. Löfvenmark, C., et al., Evaluation of an educational programme for family members of patients living with heart failure: a randomised controlled trial. Journal of Clinical Nursing, 2013. 22(1-2): p. 115-126.
  5. Afzali, S., et al., The effect of progressive muscle relaxation program (PMR) on anxiety of patients undergoing coronary heart angiography. Journal of Shahrekord Uuniversity of Medical Sciences, 2009. 11(3): p. 77-84.
  6. Hadaegh, F., et al., Prevalence of coronary heart disease among Tehran adults: Tehran Lipid and Glucose Study. EMHJ-Eastern Mediterranean Health Journal, 15 (1), 157-166, 2009, 2009.
  7. Asadi, P. and A.H. Asadi, Evaluation the level of knowledge and attitude of the Medical personnel and Patient Companions Referred to Ibn Sina Hospital in the Use of ECT to Treatment Patients with Major Depression in Bandar Abbas. Jundishapur Scientific Medical Journal, 2020. 19(5): p. 385-397.
  8. Fakhrzadeh, H., et al., The relationship between ischemic heart disease and coronary risk factors in population aged over 25 in Qazvin: A population-based study. Journal of Inflammatory Diseases, 2005. 9(2): p. 26-34.
  9. Kazemy, T. and G. Sharifzadeh, Ten-year changes in mortality and risk factors in acute myocardial infarction in Birjand (1994-2003). Internal Medicine Today, 2004. 10(3): p. 38-42.
  10. Gander, J., et al., Peer Reviewed: Factors Related to Coronary Heart Disease Risk Among Men: Validation of the Framingham Risk Score. Preventing chronic disease, 2014. 11.
  11. Fuster, V., et al., Atherothrombosis and high-risk plaque: part I: evolving concepts. Journal of the American College of Cardiology, 2005. 46(6): p. 937-954.
  12. Huang, C., et al., Sugar sweetened beverages consumption and risk of coronary heart disease: a meta-analysis of prospective studies. Atherosclerosis, 2014. 234(1): p. 11-16.
  13. Coughlin, S.S., Post-traumatic stress disorder and cardiovascular disease. The open cardiovascular medicine journal, 2011. 5: p. 164.
  14. Hasani, H., Clinical evaluation of instent restenosis in coronary artery disease. KAUMS Journal (FEYZ), 2005. 9(1): p. 40-44.
  15. Moustapha, A., et al., Percutaneous and surgical interventions for in-stent restenosis: long-term outcomes and effect of diabetes mellitus. Journal of the American College of Cardiology, 2001. 37(7): p. 1877-1882.
  16. Sukhija, R., et al., Increased fasting plasma insulin concentrations are associated with the severity of angiographic coronary artery disease. Angiology, 2005. 56(3): p. 249-251.
  17. Kosuge, M., et al., Different clinical and coronary angiographic findings according to ratios of total cholesterol to high-density lipoprotein cholesterol during the acute phase of myocardial infarction. Journal of Cardiology, 2004. 43(6): p. 251-258.
  18. Song, W., et al., Mediating effects of lipids on the association between smoking and coronary artery disease risk among Chinese. Lipids in Health and Disease, 2020. 19(1): p. 1-7.
  19. Ebrahimzadeh, F., et al., Prediction of coronary artery restenosis in patients undergoing angioplasty. Journal of Babol University of Medical Sciences, 2018. 20(5): p. 30-37.
  20. Li, M., et al., Incidence and risk factors of in-stent restenosis after percutaneous coronary intervention in patients from southern China. European Journal of Medical Research, 2022. 27(1): p. 1-7.
  21. Ghariani, A., et al., Outcomes and prognostic factors of patients treated for in-stent restenosis: a retrospective single-center experience. The Egyptian Heart Journal, 2022. 74(1): p. 1-7.
  22. Lau, K.-W., et al., Clinical and angiographic outcome after angiography-guided stent placement in small coronary vessels. American Heart Journal, 2000. 139(5): p. 830-839.
  23. Sadeghi, M., et al., Association between severity of coronary disease and apolipoproteins A and B. Iranian Journal of Endocrinology and Metabolism, 2011. 13(2): p. 173-178.
  24. Chan, D. and G. Watts, Apolipoproteins as markers and managers of coronary risk. Journal of the Association of Physicians, 2006. 99(5): p. 277-287.
  25. Steinberg, D.H., et al., Impact of in-stent restenosis on death and myocardial infarction. The American journal of cardiology, 2007. 100(7): p. 1109-1113.
  26. Alraies, M.C., et al., Diagnosis and management challenges of in-stent restenosis in coronary arteries. World journal of cardiology, 2017. 9(8): p. 640.
  27. Jukema, J.W., et al., Restenosis after PCI. Part 1: pathophysiology and risk factors. Nature Reviews Cardiology, 2012. 9(1): p. 53-62.
  28. Latif, F., et al., In-hospital and 1-year outcomes among percutaneous coronary intervention patients with chronic kidney disease in the era of drug-eluting stents: a report from the EVENT (Evaluation of Drug Eluting Stents and Ischemic Events) registry. JACC: Cardiovascular Interventions, 2009. 2(1): p. 37-45.
  29. Zhang, J., et al., Risk factors for in-stent restenosis after coronary stent implantation in patients with coronary artery disease: A retrospective observational study. Medicine, 2022. 101(47).
  30. Zbinden, R., et al., Impact of stent diameter and length on in‐stent restenosis after DES vs BMS implantation in patients needing large coronary stents—a clinical and health‐economic evaluation. Cardiovascular therapeutics, 2017. 35(1): p. 19-25.
  31. Ebrahimzadeh, F., et al., Timing the incidence of restenosis and some effective factors in patients undergoing angioplasty using extended cox regression model. Journal of Mazandaran University of Medical Sciences, 2017. 26(146): p. 56-67.
  32. Nasseryan, J., et al., The association of demographic and clinical factors with the frequency of restenosis in patients undergoing angioplasty using negative binomial regression. Iranian Journal of Epidemiology, 2016. 12(2): p. 9-17.
  33. Stefanini, G.G., et al., The impact of renal impairment on long-term safety and effectiveness of drug-eluting stents. PLoS One, 2014. 9(9): p. e106450.
  34. Aoyama, Y., et al., Impact of chronic kidney disease on a re-percutaneous coronary intervention for sirolimus-eluting stent restenosis. Coronary artery disease, 2012. 23(8): p. 528-532.
  35. Nasseryan, J., et al., Assessment of the clinical factors related to the prevalence of restenosis in patients undergone angioplasty using logistic regression. Journal of Health Promotion Management, 2016. 5(2): p. 1-9.
Iranian Heart Journal
Volume 25, Issue 4
Autumn 2024
Pages 31-42